111 Inc
YI7.455USD
+0.060+0.81%
交易中 （美东）报价延迟15分钟
377.78M总市值
亏损市盈率 TTM
关于 111 Inc 公司
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
111 Inc简介
公司代码YI
公司名称111 Inc
上市日期Sep 12, 2018
CEOLiu (Junling)
员工数量1238
证券类型Depository Receipt
年结日Sep 12
公司地址3-4/F, No.295 Zuchongzhi Road
城市SHANGHAI
上市交易所NASDAQ OMX - NASDAQ BASIC
国家China
邮编201203
电话862120536666
网址http://corporate.111.com.cn/
公司代码YI
上市日期Sep 12, 2018
CEOLiu (Junling)
111 Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Product Revenues
2.98B
99.44%
Service Revenues
16.89M
0.56%
由于公司未披露，未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Product Revenues
2.98B
99.44%
Service Revenues
16.89M
0.56%
股东统计
更新时间: 1月30日 周五
更新时间: 1月30日 周五
持股股东
股东类型
持股股东
持股股东
占比
First Pharmacia International
8.57%
Susquehanna International Group, LLP
0.59%
Renaissance Technologies LLC
0.26%
Morgan Stanley & Co. LLC
0.10%
Serenus Wealth Advisors, LLC
0.09%
其他
90.39%
持股股东
持股股东
占比
First Pharmacia International
8.57%
Susquehanna International Group, LLP
0.59%
Renaissance Technologies LLC
0.26%
Morgan Stanley & Co. LLC
0.10%
Serenus Wealth Advisors, LLC
0.09%
其他
90.39%
股东类型
持股股东
占比
Corporation
8.57%
Investment Advisor
0.68%
Hedge Fund
0.26%
Research Firm
0.10%
Investment Advisor/Hedge Fund
0.05%
其他
90.33%
机构持股
更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
25
52.21K
6.89%
--
2025Q4
37
55.41K
1.09%
-397.88K
2025Q3
42
1.21M
23.79%
-403.88K
2025Q2
48
1.99M
39.33%
-416.92K
2025Q1
49
2.00M
39.53%
-387.91K
2024Q4
51
2.26M
44.72%
+133.67K
2024Q3
43
1.99M
39.36%
-280.22K
2024Q2
45
2.17M
42.88%
-87.92K
2024Q1
52
2.15M
42.65%
-125.45K
2023Q4
54
2.16M
44.89%
-28.04K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
First Pharmacia International
434.53K
8.57%
--
--
Mar 31, 2025
Susquehanna International Group, LLP
29.91K
0.59%
+15.14K
+102.54%
Sep 30, 2025
Renaissance Technologies LLC
13.01K
0.26%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
5.14K
0.1%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
2.44K
0.05%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
1.45K
0.03%
-4.67K
-76.32%
Sep 30, 2025
SBI Securities Co., Ltd.
184.00
0%
-40.00
-17.86%
Sep 30, 2025
J.P. Morgan Securities LLC
23.00
0%
+15.00
+187.50%
Sep 30, 2025
Parametric Portfolio Associates LLC
27.00
0%
--
--
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
SPDR S&P Emerging Markets Small Cap ETF
0%
SPDR Portfolio Emerging Markets ETF
0%
SPDR S&P Emerging Asia Pacific ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
占比0%
SPDR Portfolio Emerging Markets ETF
占比0%
SPDR S&P Emerging Asia Pacific ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
公告日期
除权除息日
类型
比率
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
